Aster DM Healthcare's Q4 FY 2025-26 Quarterly Results

Result Summary

• Aster DM Healthcare Ltd reported a 0.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 18.1%.
• Its expenses for the quarter were down by 2.5% QoQ and up 15.7% YoY.
• The net profit increased 161.9% QoQ and increased 79.5% YoY.
• The earnings per share (EPS) of Aster DM Healthcare Ltd stood at 2.71 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Aster DM Healthcare Ltd is a prominent player in the healthcare industry, known for its comprehensive range of healthcare services. The company operates hospitals, clinics, and pharmacies, primarily serving the Middle Eastern and Indian markets. Aster DM Healthcare focuses on providing quality medical care and has established a significant presence in its operational regions. As of the data available up to October 2023, the company has been actively expanding its facilities and services to cater to the growing healthcare demands. However, specific recent major developments are not available in the provided data.

Revenue

In Q4FY26, Aster DM Healthcare Ltd reported a total income of ₹1,218.58 crores, marking a slight quarter-over-quarter increase of 0.4% from ₹1,213.73 crores in Q3FY26. When compared to the same period in the previous year (Q4FY25), the company experienced an 18.1% increase from ₹1,031.62 crores. This growth reflects the company's ability to enhance its revenue stream over the year. The consistent revenue growth year-over-year indicates the company’s strategy to expand its operations and possibly increase its market share in the healthcare sector.

Profitability

The profitability of Aster DM Healthcare Ltd saw a notable improvement in Q4FY26. The profit before tax in this quarter stood at ₹171.88 crores, which is a significant 53.7% increase from ₹111.80 crores reported in Q3FY26 and a 70.9% rise from ₹100.55 crores in Q4FY25. The reduction in tax expenses by 78.0% quarter-over-quarter, from ₹44.40 crores in Q3FY26 to ₹9.77 crores in Q4FY26, contributed to a substantial boost in profit after tax, which was ₹153.58 crores. This represents a 161.9% increase from the previous quarter and a 79.5% increase year-over-year. Earnings per share increased similarly, reflecting the company's enhanced profitability during this period.

Operating Metrics

Aster DM Healthcare Ltd's operational efficiency is highlighted by its ability to control expenses effectively. Total expenses in Q4FY26 amounted to ₹1,047.03 crores, marking a 2.5% decrease from ₹1,073.64 crores recorded in Q3FY26, yet a 15.7% increase from ₹904.65 crores in Q4FY25. This indicates a careful management of costs relative to the income generated. The company’s earnings per share rose to ₹2.71 in Q4FY26, compared to ₹1.02 in Q3FY26 and ₹1.58 in Q4FY25, demonstrating a significant improvement in per-share earnings. These metrics suggest that the company has maintained a strong operational performance, supporting its overall financial health.